SiriusPoint Ltd's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), SiriusPoint Ltd reported revenue of $3.2B (+23.1% year on year) and net income of $460.1M (+127.3% year on year).
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Net earned premium | $2.6B | $2.3B | $2.4B | $2.3B |
| Net investment income | $274.8M | $303.6M | $283.7M | $113.3M |
| Net realized and unrealized investment losses | ($2.9M) | ($88.7M) | ($10.0M) | ($225.5M) |
| Net investment income and net realized and unrealized investment losses | $271.9M | $224.6M | $272.7M | ($322.7M) |
| Other revenues | $339.4M | $184.2M | $38.4M | $110.2M |
| Loss on settlement and change in fair value of liability-classified capital instruments | $0 | ($148.5M) | — | — |
| Total revenues | $3.2B | $2.6B | $2.7B | $2.1B |
| Loss and loss adjustment expenses incurred, net | $1.5B | $1.4B | $1.4B | $1.6B |
| Acquisition costs, net | $583.6M | $516.9M | $472.7M | $461.9M |
| Other underwriting expenses | $187.9M | $181.7M | $196.3M | $184.5M |
| Net corporate and other expenses | $257.0M | $232.1M | $258.2M | $312.8M |
| Intangible asset amortization | $10.9M | $11.9M | $11.1M | $8.1M |
| Interest expense | $79.7M | $69.6M | $64.1M | $38.6M |
| Foreign exchange (gains) losses | $25.2M | ($10.0M) | $34.9M | ($66.0M) |
| Total expenses | $2.7B | $2.4B | $2.4B | $2.5B |
| Income before income tax (expense) benefit | $541.3M | $233.1M | $318.7M | ($422.7M) |
| Income tax (expense) benefit | ($81.2M) | ($30.7M) | $45.0M | $36.7M |
| Net income | $460.1M | $202.4M | $363.7M | ($386.0M) |
| Net income attributable to noncontrolling interests | ($500.0K) | ($2.5M) | ($8.9M) | ($800.0K) |
| Net income available to SiriusPoint | $459.6M | $199.9M | $354.8M | ($386.8M) |
| Dividends on Series B preference shares | -16.0M | -16.0M | -16.0M | -16.0M |
| Net income available to SiriusPoint common shareholders, basic | $443.6M | $183.9M | $338.8M | ($402.8M) |
| Net income available to SiriusPoint common shareholders, diluted | $443.6M | $183.9M | $338.8M | ($402.8M) |
| Basic earnings per share available to SiriusPoint common shareholders (in dollars per share) | $3.80 | $1.06 | $1.93 | -$2.51 |
| Diluted earnings per share available to SiriusPoint common shareholders (in dollars per share) | $3.64 | $1.04 | $1.85 | -$2.51 |
| Basic (in shares) | 116.5M | 166.5M | 163.3M | 160.2M |
| Diluted (in shares) | 121.6M | 169.5M | 169.6M | 160.2M |
| Line item | Jun 30, 2026 · Q2 | Mar 31, 2026 · Q1 | Sep 30, 2025 · Q3 | Jun 30, 2025 · Q2 |
|---|---|---|---|---|
| Net earned premium | $640.3M | $638.9M | $647.7M | $652.0M |
| Net investment income | $65.5M | $66.4M | $66.5M | $68.2M |
| Net investment gains (losses) | $7.9M | $11.4M | $6.2M | $700.0K |
| Other revenues | $30.4M | $57.9M | $35.5M | $27.3M |
| Total revenues | $744.1M | $774.6M | $755.9M | $748.2M |
| Loss and loss adjustment expenses incurred, net | $358.2M | $362.9M | $372.9M | $372.6M |
| Acquisition costs, net | $156.8M | $147.8M | $139.8M | $140.9M |
| Other underwriting expenses | $51.8M | $50.5M | $43.6M | $48.3M |
| Net corporate and other expenses | $73.7M | $71.2M | $62.5M | $70.9M |
| Intangible asset amortization | $2.4M | $2.6M | $2.8M | $2.8M |
| Interest expense | $18.7M | $16.8M | $21.0M | $21.1M |
| Foreign exchange (gains) losses | ($1.8M) | $1.3M | $2.4M | $16.7M |
| Total expenses | $659.8M | $653.1M | $645.0M | $673.3M |
| Income before income tax expense | $84.3M | $121.5M | $110.9M | $74.9M |
| Income tax expense | ($15.8M) | ($19.2M) | ($20.2M) | ($11.6M) |
| Net income | $68.5M | $102.3M | $90.7M | $63.3M |
| Net (income) loss attributable to noncontrolling interests | $100.0K | ($100.0K) | $100.0K | ($100.0K) |
| Net income available to SiriusPoint | $68.6M | $102.2M | $90.8M | $63.2M |
| Dividends on Series B preference shares | 0 | -2.6M | -4.0M | -4.0M |
| Net income available to SiriusPoint common shareholders, basic | $68.6M | $99.6M | $86.8M | $59.2M |
| Net income available to SiriusPoint common shareholders, diluted | $68.6M | $99.6M | $86.8M | $59.2M |
| Basic earnings per share available to SiriusPoint common shareholders (in dollars per share) | $0.59 | $0.85 | $0.74 | $0.51 |
| Diluted earnings per share available to SiriusPoint common shareholders (in dollars per share) | $0.58 | $0.82 | $0.73 | $0.50 |
| Basic (in shares) | 116.7M | 116.7M | 116.7M | 116.5M |
| Diluted (in shares) | 119.0M | 121.7M | 118.8M | 118.7M |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Debt securities, available for sale, at fair value, net of allowance for credit losses of $0.0 (2024 - $1.1) (cost - $5,118.3; 2024 - $5,143.8) | $5.2B | $5.1B | $4.8B | $2.6B |
| Debt securities, trading, at fair value (cost - $114.6; 2024 - $187.3) | $90.3M | $162.2M | $534.9M | $1.5B |
| Short-term investments, at fair value (cost - $28.4; 2024 - $95.3) | $28.3M | $95.8M | $371.6M | $984.6M |
| Other long-term investments, at fair value (cost - $421.9; 2024 - $438.2) (includes related party investments at fair value of $216.1 (2024 - $217.2) | $315.1M | $200.0M | $308.5M | $377.2M |
| Total investments | $5.6B | $5.7B | $6.1B | $5.7B |
| Cash and cash equivalents | $731.2M | $682.0M | $969.2M | $705.3M |
| Restricted cash and cash equivalents | $171.2M | $212.6M | $132.1M | $208.4M |
| Due from brokers | $7.5M | $11.2M | $5.6M | $4.9M |
| Interest and dividends receivable | $47.1M | $44.0M | $42.3M | $26.7M |
| Insurance and reinsurance balances receivable, net | $2.3B | $2.1B | $2.0B | $1.9B |
| Deferred acquisition costs, net | $384.1M | $327.5M | $308.9M | $294.9M |
| Unearned premiums ceded | $487.4M | $463.9M | $449.2M | $348.8M |
| Loss and loss adjustment expenses recoverable, net | $2.1B | $2.3B | $2.3B | $1.4B |
| Deferred tax asset | $267.7M | $297.0M | $293.6M | $200.3M |
| Intangible assets | $121.2M | $140.8M | $152.7M | $163.8M |
| Other assets | $272.1M | $270.7M | $175.9M | $157.9M |
| Assets held for sale | $115.2M | — | — | — |
| Total assets | $12.6B | $12.5B | $12.9B | $11.0B |
| Loss and loss adjustment expense reserves | $5.8B | $5.7B | $5.6B | $5.3B |
| Unearned premium reserves | $1.9B | $1.6B | $1.6B | $1.5B |
| Reinsurance balances payable | $1.4B | $1.8B | $1.7B | $813.6M |
| Deferred gain on retroactive reinsurance | $0 | $8.5M | $27.9M | — |
| Debt | $688.6M | $639.1M | $786.2M | $778.0M |
| Due to brokers | $5.5M | $18.0M | $6.2M | $0 |
| Deferred tax liability | $73.0M | $76.2M | $68.7M | $59.8M |
| Share repurchase liability | $0 | $483.0M | — | — |
| Other liabilities | $246.1M | — | — | — |
| Total liabilities | $10.1B | $10.6B | $10.3B | $9.0B |
| Series B preference shares (par value $0.10; authorized and issued: 8,000,000) | 200.0M | 200.0M | 200.0M | 200.0M |
| Common shares (issued and outstanding: 116,989,799; 2024 - 116,429,057) | 11.7M | 11.6M | 16.8M | 16.2M |
| Additional paid-in capital | $967.7M | $945.0M | $1.7B | $1.6B |
| Retained earnings | $1.2B | $784.9M | $601.0M | $262.2M |
| Accumulated other comprehensive income (loss), net of tax | $61.9M | ($4.1M) | $3.1M | ($45.0M) |
| Shareholders’ equity attributable to SiriusPoint shareholders | $2.5B | $1.9B | $2.5B | $2.1B |
| Noncontrolling interests | $1.1M | $1.4M | $16.7M | $7.9M |
| Total shareholders’ equity | $2.5B | $1.9B | $2.5B | $2.1B |
| Total liabilities, noncontrolling interests and shareholders’ equity | $12.6B | $12.5B | $12.9B | $11.0B |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 |
|---|---|---|---|---|
| Debt securities, available for sale, at fair value, net of allowance for credit losses of $0.0 (2025 - $0.0) (cost - $5,180.5; 2025 - $5,118.3) | $5.2B | $4.9B | $5.1B | $4.7B |
| Debt securities, trading, at fair value (cost - $88.6; 2025 - $114.6) | $64.8M | $86.0M | $98.7M | $102.9M |
| Short-term investments, at fair value (cost - $7.2; 2025 - $28.4) | $7.5M | $32.5M | $24.6M | $54.9M |
| Other long-term investments, at fair value (cost - $399.3; 2025 - $421.9) (includes related party investments at fair value of $224.5 (2025 - $216.1)) | $285.8M | $295.4M | $318.3M | $320.1M |
| Total investments | $5.5B | $5.3B | $5.6B | $5.2B |
| Cash and cash equivalents | $614.8M | $856.9M | $582.4M | $732.4M |
| Restricted cash and cash equivalents | $131.1M | $153.8M | $135.3M | $190.8M |
| Due from brokers | $32.6M | $40.1M | $10.0M | $8.2M |
| Interest and dividends receivable | $44.2M | $41.4M | $43.9M | $42.5M |
| Insurance and reinsurance balances receivable, net | $2.6B | $2.4B | $2.3B | $2.3B |
| Deferred acquisition costs, net | $408.7M | $403.4M | $381.1M | $379.5M |
| Unearned premiums ceded | $630.7M | $573.3M | $487.1M | $484.0M |
| Loss and loss adjustment expenses recoverable, net | $2.0B | $2.0B | $2.2B | $2.3B |
| Deferred tax asset | $267.4M | $256.7M | $282.2M | $297.1M |
| Goodwill | $18.6M | $18.6M | — | — |
| Intangible assets | $137.4M | $139.8M | $123.6M | $135.1M |
| Other assets | $253.1M | $251.2M | $330.0M | $318.3M |
| Assets held for sale | $0 | $0 | $43.1M | — |
| Total assets | $12.7B | $12.5B | $12.5B | $12.4B |
| Loss and loss adjustment expense reserves | $5.8B | $5.7B | $5.8B | $5.8B |
| Unearned premium reserves | $2.1B | $2.0B | $1.9B | $1.9B |
| Reinsurance balances payable | $1.5B | $1.5B | $1.5B | $1.5B |
| Debt | $675.5M | $679.6M | $682.5M | $678.4M |
| Due to brokers | $23.3M | $3.4M | $27.5M | $9.0M |
| Deferred tax liability | $73.1M | $73.4M | $78.5M | $89.6M |
| Other liabilities | $271.8M | $244.3M | $263.2M | $260.6M |
| Total liabilities | $10.4B | $10.2B | $10.2B | $10.2B |
| Series B preference shares (2025 - par value $0.10; authorized and issued: 8,000,000) | 0 | 0 | 200.0M | 200.0M |
| Common shares (issued and outstanding: 116,065,965 (2025 - 116,989,799) | 11.6M | 11.6M | 11.7M | 11.7M |
| Additional paid-in capital | $888.9M | $956.4M | $957.4M | $945.8M |
| Retained earnings | $1.4B | $1.3B | $988.5M | $901.7M |
| Accumulated other comprehensive income (loss), net of tax | ($21.3M) | $6.3M | $52.3M | $46.5M |
| Shareholders’ equity attributable to SiriusPoint shareholders | $2.3B | $2.3B | $2.2B | $2.1B |
| Noncontrolling interests | $800.0K | $1.0M | $1.1M | $1.1M |
| Total shareholders’ equity | $2.3B | $2.3B | $2.2B | $2.1B |
| Total liabilities, noncontrolling interests and shareholders’ equity | $12.7B | $12.5B | $12.5B | $12.4B |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Net income | $460.1M | $202.4M | $363.7M | ($386.0M) |
| Share compensation | $35.9M | $20.7M | $21.4M | $30.5M |
| Net realized and unrealized loss on investments and derivatives | $2.9M | $88.7M | $5.9M | $207.6M |
| Change in fair value of liability-classified capital instruments | $0 | $31.9M | — | — |
| Gain from sale of consolidated subsidiary | ($222.4M) | — | $0 | $0 |
| Amortization of premium and accretion of discount, net | ($34.6M) | ($61.2M) | ($67.1M) | ($17.2M) |
| Amortization of intangible assets | $10.9M | $11.9M | $11.1M | $8.1M |
| Other items, net | $49.5M | ($42.4M) | $23.7M | ($33.8M) |
| Insurance and reinsurance balances receivable, net | ($206.7M) | ($87.9M) | ($84.3M) | ($164.7M) |
| Deferred acquisition costs, net | ($56.6M) | ($18.6M) | ($14.0M) | ($76.1M) |
| Unearned premiums ceded | ($23.5M) | ($14.7M) | ($100.4M) | ($106.0M) |
| Loss and loss adjustment expenses recoverable, net | $213.0M | ($20.2M) | ($918.9M) | ($160.9M) |
| Deferred tax asset/liability | $22.2M | $11.2M | ($84.4M) | ($53.9M) |
| Other assets | ($25.1M) | ($110.0M) | ($28.8M) | ($36.9M) |
| Interest and dividends receivable | ($3.1M) | ($1.7M) | ($15.6M) | ($18.4M) |
| Loss and loss adjustment expense reserves | $128.6M | $45.8M | $339.4M | $427.3M |
| Unearned premium reserves | $216.2M | $11.9M | $106.2M | $322.7M |
| Deferred gain on retroactive reinsurance | ($8.5M) | ($19.4M) | $27.9M | — |
| Reinsurance balances payable | ($334.0M) | $44.9M | $923.6M | $125.3M |
| Other liabilities | ($7.2M) | — | — | — |
| Held for sale asset | ($115.2M) | — | — | — |
| Net cash provided by operating activities | $102.4M | $74.7M | $581.3M | $293.3M |
| Purchases of debt securities, available-for-sale | ($2.3B) | ($2.3B) | — | — |
| Purchases of short-term investments | ($122.5M) | ($432.9M) | — | — |
| Purchases of other investments | ($23.4M) | ($28.6M) | — | — |
| Proceeds from sales and maturities of debt securities, available-for-sale | $2.4B | $1.9B | — | — |
| Proceeds from sales and maturities of debt securities, trading and short-term investments | $240.4M | $1.1B | — | — |
| Proceeds from sales and maturities of other investments | $12.5M | $64.0M | — | — |
| Change in due to/from brokers, net | ($8.8M) | $6.2M | $5.5M | $4.5M |
| Proceeds from sale of consolidated subsidiary, net of cash sold | $224.9M | — | $0 | $0 |
| Net cash provided by investing activities | $424.2M | $343.6M | ($332.2M) | ($1.3B) |
| Taxes paid on withholding shares | -6.3M | -9.8M | -11.5M | -7.1M |
| Repayment of loans under an agreement to repurchase | $0 | $0 | ($18.0M) | $17.6M |
| Cash dividends paid to preference shareholders | ($16.0M) | ($16.0M) | ($16.0M) | ($16.0M) |
| Payment of redemption of debt | $0 | ($517.9M) | — | — |
| Proceeds from issuance of debt, net of costs | $0 | $393.9M | — | — |
| Settlement of liability-classified capital instruments | $0 | ($99.2M) | ($38.5M) | — |
| Net proceeds from exercise of options | $900.0K | $18.4M | $27.8M | — |
| Net payments on deposit liability contracts | ($5.8M) | ($94.4M) | ($6.1M) | ($14.0M) |
| Purchases of SiriusPoint common shares under share repurchase program | -490.8M | -299.7M | 0 | -5.0M |
| Change in total noncontrolling interests, net | ($800.0K) | ($300.0K) | $800.0K | $800.0K |
| Net cash used in financing activities | ($518.8M) | ($625.0M) | ($61.5M) | ($23.7M) |
| Net increase (decrease) in cash, cash equivalents and restricted cash | $7.8M | ($206.7M) | $187.6M | ($1.0B) |
| Cash, cash equivalents and restricted cash at beginning of period | $894.6M | $1.1B | $913.7M | $1.9B |
| Cash, cash equivalents and restricted cash at end of period | $902.4M | — | — | — |
| Line item | Jun 30, 2026 · YTD | Mar 31, 2026 · Q1 | Sep 30, 2025 · YTD | Jun 30, 2025 · YTD |
|---|---|---|---|---|
| Net income | $170.8M | $102.3M | $216.0M | $125.3M |
| Share compensation | $16.4M | $10.5M | $24.1M | $12.2M |
| Net realized and unrealized gain on investments and derivatives | ($19.3M) | ($11.4M) | ($6.6M) | ($400.0K) |
| Amortization of premium and accretion of discount, net | ($13.7M) | ($8.8M) | ($28.6M) | ($19.8M) |
| Amortization of intangible assets | $5.0M | $2.6M | $8.5M | $5.7M |
| Other items, net | ($23.5M) | ($14.0M) | $39.1M | $32.5M |
| Insurance and reinsurance balances receivable, net | ($346.4M) | ($160.4M) | ($237.9M) | ($236.6M) |
| Deferred acquisition costs, net | ($24.6M) | ($19.3M) | ($53.6M) | ($52.0M) |
| Unearned premiums ceded | ($143.3M) | ($85.9M) | ($23.2M) | ($20.1M) |
| Loss and loss adjustment expenses recoverable, net | $110.9M | $82.1M | $152.4M | $51.4M |
| Deferred tax asset/liability | $11.7M | $20.0M | $10.0M | $10.2M |
| Other assets | $21.5M | $24.9M | ($69.0M) | ($54.5M) |
| Interest and dividends receivable | $2.9M | $5.7M | $100.0K | $1.5M |
| Loss and loss adjustment expense reserves | ($32.2M) | ($49.8M) | $157.8M | $163.5M |
| Unearned premium reserves | $264.3M | $135.8M | $228.7M | $214.8M |
| Deferred gain on retroactive reinsurance | $0 | $0 | ($8.5M) | ($8.5M) |
| Reinsurance balances payable | $13.7M | $7.4M | ($289.5M) | ($241.7M) |
| Other liabilities | $7.3M | ($15.0M) | ($6.0M) | ($10.3M) |
| Held for sale asset | $115.2M | $115.2M | ($19.5M) | — |
| Net cash provided by (used in) operating activities | $136.7M | $141.9M | $128.8M | ($26.8M) |
| Purchases of debt securities, available-for-sale | ($980.6M) | ($274.2M) | ($1.7B) | ($811.2M) |
| Purchases of short-term investments | ($16.3M) | ($13.8M) | ($101.6M) | ($89.2M) |
| Purchases of other investments | ($4.4M) | ($3.0M) | ($19.0M) | ($9.7M) |
| Proceeds from sales and maturities of debt securities, available-for-sale | $931.8M | $504.9M | $1.8B | $1.3B |
| Proceeds from sales and maturities of debt securities, trading and short-term investments | $59.6M | $11.0M | $239.8M | $191.0M |
| Proceeds from sales and maturities of other investments | $44.2M | $28.2M | $16.0M | $8.7M |
| Change in due to/from brokers, net | ($7.3M) | ($34.7M) | $10.7M | ($6.0M) |
| Business acquisitions, net (cash and restricted cash acquired of $4.9) | ($29.4M) | ($29.4M) | — | — |
| Net cash provided by (used in) investing activities | ($2.4M) | $189.0M | $234.9M | $565.8M |
| Redemption of preference shares | -200.0M | -200.0M | — | — |
| Purchases of SiriusPoint common shares under share repurchase program | -73.3M | -21.9M | -490.8M | -490.8M |
| Net proceeds from exercise of options | $0 | — | $800.0K | $600.0K |
| Net proceeds (payments) on deposit liability contracts | $7.6M | $3.6M | ($9.7M) | ($7.3M) |
| Cash dividends paid to preference shareholders | ($2.6M) | ($3.9M) | ($12.0M) | ($8.0M) |
| Taxes paid on withholding shares | -22.2M | -200.0K | -4.6M | -4.1M |
| Change in total noncontrolling interests, net | ($300.0K) | ($200.0K) | ($700.0K) | ($800.0K) |
| Net cash used in financing activities | ($290.8M) | ($222.6M) | ($517.0M) | ($510.4M) |
| Net increase (decrease) in cash, cash equivalents and restricted cash | ($156.5M) | $108.3M | ($153.3M) | $28.6M |
| Cash, cash equivalents and restricted cash at beginning of period | $902.4M | $902.4M | $894.6M | $894.6M |
| Cash, cash equivalents and restricted cash at end of period | $745.9M | $1.0B | $717.7M | $923.2M |
SiriusPoint Ltd score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.